Document

Data Variable Options

ICR 202605-0920-005 · OMB 0920-0696 · Object 169126700.

Document Viewer [docx]

Status: Original and derived artifacts are available for this document.

Download: docx | pdf | html

Primary: docxSource: application/vnd.openxmlformats-officedocument.wordprocessingml.document
Loading document viewer…
Document Metadata
File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleData Variable Options
AuthorHeitgerd, Janet (CDC/OID/NCHHSTP)
Last Modified ByWriter
File Modified2018-08-20
File Created2026-06-04
Conversion Statecomplete
Extracted Text
Attachment 5B. National HIV Prevention Program Monitoring and Evaluation (NHM&E) Data Variable Options (OMB 0920-0696, Exp. 02/28/2019)
Option 1 is available through December 31, 2018 for health departments funded under PS18-1802. However, additional time may be granted to those health departments unable to transition to Option 2 by that date. Option 1 is required for community based organizations funded under PS15-1502 through the last year of current funding (June 30, 2020) and those funded under PS17-1704 through March 31, 2019. 
Option 2 is available to health departments beginning July 1, 2018 and required for all health departments on January 1, 2019. Option 2 will be required for any new CBO NOFO. New Variables will be available following OMB approval. 
Variable Number
Variable Name
Option 1:
NHM&E Requirements
Option 2:
NHM&E Requirements
Status
Agency




A01
Agency Name



A01a
Agency ID



A02
Jurisdiction



A27
CBO Agency Name



A28
CBO Agency ID



Site




S01
Site ID



S04
Site Type



S08
Site – County



S09
Site – State



S10
Site - Zip Code



S03
Site Name



 CDC




CDC06
CDC Variable 6



CDC07
CDC Variable 7



CDC08
CDC Variable 8



CDC09
CDC Variable 9



CDC10
CDC Variable 10



 Client




G101
Date Client Demographic Data Collected



G103
Local Client ID



G112
Date of Birth - Year



G114
Ethnicity



G116
Race



G120
State/Territory of Residence



G123
Assigned Sex at Birth



G124
Current Gender Identity



G124a
Specify Current Gender Identity



G132
Client – County



G134
Client - Zip Code



G200
Date Client Risk Collected



G200_1
Client Behavioral Risk Profile



G204
Previous HIV Test



G205
Self-Reported HIV Test Result



G209
Pregnant (Only If Female)



G210
In Prenatal Care (Only if Pregnant)



G211_01
Injection Drug Use



G211_08
Share Drug Injection Equipment



G212
Additional Client Risk Factors



G216a
Vaginal or Anal Sex with a Male



G216b
Vaginal or Anal Sex with a Female



G216c
Vaginal or Anal Sex with a Transgender Person



G217a
Vaginal or Anal Sex without a Condom with a Male



G217b
Vaginal or Anal Sex without a Condom with a Female



G217c
Vaginal or Anal Sex without a Condom with a Transgender Person



G218a
Vaginal or Anal Sex with a Male IDU



G218b
Vaginal or Anal Sex with a Female IDU



G218c
Vaginal or Anal Sex with a Transgender IDU



G219a
Vaginal or Anal Sex with HIV-Positive Male



G219b
Vaginal or Anal Sex with HIV-Positive Female



G219c
Vaginal or Anal Sex with HIV-Positive Transgender Person



G220
Vaginal or Anal Sex with MSM (female only)



G222
Vaginal or Anal Sex without a Condom (PS only)



G223
Vaginal or Anal Sex with an IDU (PS only)



G205a
Previous HIV Test Result



G400
In the past 5 years, has the client/patient had sex with a male?



G401
In the past 5 years, has the client/patient had sex with a female?



G402
In the past 5 years, has the client/patient injected drugs that were not prescribed to him/her by a medical care provider?



G403
In the past 5 years, has the client/patient had sex with a transgender person?


New
 Testing 1




H04a
Test Form ID



H06
Session Date



H800
Has the client/patient ever heard of PrEP, the medicine taken daily to reduce the risk for getting HIV?



H802
Has the client/patient used PrEP anytime in the last 12 months?



H04c
eHARS State Number



H04d
eHARS City/County Number



 Partner Services




PCR101
Case Number



PCR103
Case Open Date



PCR104
Case Close Date



PCR108
Date of Report



PCR109
Reported to Surveillance



PCR200
Date Collected



PCR202a
Local PS ID



PCR207
Partner Type



PCR209
Notification Plan



PCR104a
Care Status at Case Close Date



 Testing 2




X103
Test Technology



X104
HIV Test Election



X104a
HIV Test Election



X105
Sample Date



X110
Test Result



X111
Result Provided



X115
If Result Not Provided, Why



X124
Basis of Final Determination



X125
HIV Test Result, Final Determination



X126
Preliminary Positive point-of-care rapid test



X126a
Specimen Collection Date of Preliminary Positive point-of-care rapid test



X127
Tests for co-infections



X127a
Syphilis Test



X127b
Gonorrhea



X127c
Chlamydial infection



X127d
Hepatitis C



X135
Worker ID



X136
In Surveillance System or Records



X137
Program Announcement or Program Strategy



X137-1
Specify Program Announcement/Strategy



X138
Client HIV Status



X150
Has the client/patient ever had a positive HIV test?



X150a
If yes, date of first positive HIV test



X224
Stage of infection



X302
Attempt to Locate Outcome



X303
Reason for Unsuccessful Attempt



X303a
Specify Reason for Unsuccessful Attempt



X306
Enrollment Status



X502
Time Period for Recall (in months)



X503
Total number of claimed sex and/or needle-sharing partners within the last 12 months



X511
Total number of named sex and/or needle sharing partners within the last 12 months (with enough information to locate)



X511a
Total Number of Named Male Partners



X511b
Total Number of Named Female Partners



X511c
Total Number of Named Transgender Partners



X600
Partner Notifiability



X601
Actual Notification Method



X602
Previous HIV Test



X603
Self-Reported HIV Test Result



X604
Date of Last HIV Test



X702
Referral Date



X702a
Reason Client Not Referred to HIV Medical Care



X703_01
Referred To HIV Testing



X703_10
Referred To Medical Care



X703_14
Referred To Partner Services



X703_17
Referred To HIV Prevention Services



X706
Referral Outcome



X706b
First HIV Medical Care Appointment within 90 Days of HIV Test



X706c
HIV Medical Care Linkage



X706d
First HJV Medical Appointment Date



X712
HIV Test Performed



X712a
Coinfection Screen (Partner Services)



X712b
Co-infection Result (Partner Services)



X713
HIV Test Result



X714a
HIV Test Results Provided



X724
Client Received Prevention Services



X725
Partner Service Interview



X725a
Was the PS Interview within 30 Days of Receiving a Positive HIV Test Result



X725b
Care Status at Time of the PS Interview



X730a
Housing status in past 12 months - revised



X731
PrEP Status



X731a
Partner referred to PrEP Provider (Partner Services)



X740
Seen a Medical Care Provider in past 6 months



X741
Attend HIV medical care appointment



X741a
Appointment Date



X742
Individualized behavioral risk-reduction counseling



X743
Information provided for partner services



X744
Interviewed for partner services



X744a
Date of partner services interview



X745
Screened for perinatal HIV service coordination needs



X746
Perinatal HIV service coordination needs identified



X747
Referred for HIV perinatal service coordination



X748
Screened for PrEP eligibility



X749
Eligible for PrEP referral



X750
Referred to a PrEP Provider



X751
Assistance with linkage to a PrEP provider



X752a
Navigation services for linkage to HIV medical care – screened for need



X752b
Navigation services for linkage to HIV medical care – need identified



X752c
Navigation services for linkage to HIV medical care – provided or referred for service



X752e
Linkage services to HIV medical care – screened for need



X752f
Linkage services to HIV medical care – need identified



X752g
Linkage services to HIV medical care – provided or referred for service



X753a
Health benefits navigation and enrollment – screened for need



X753b
Health benefits navigation and enrollment – need identified



X753c
Health benefits navigation and enrollment – provided or referred to service



X754a
Medication adherence support – screened for need



X754b
Medication adherence support – need identified



X754c
Medication adherence support – provided or referred to service



X755a
Evidence-based risk reduction intervention – screened for need



X755b
Evidence-based risk reduction intervention – need identified



X755c
Evidence-based risk reduction intervention – provided or referred to service



X756a
Behavioral health services – screened for need



X756b
Behavioral health services – need identified



X756c
Behavioral health services – provided or referred to service



X758a
Social services – screened for need



X758b
Social services – need identified



X758c
Social services – provided or referred to service



 Aggregate




ME201a
Category A total PS18-1801-funded aggregate test events



ME201b
Category A total reimbursed aggregate test events



ME202a
Category A PS18-1801-funded aggregate newly diagnosed HIV-positive test events



ME202b
Category A reimbursed aggregate newly diagnosed HIV-positive testing events



CBO




CBOCL003
Client Record Number



CBOTEST001
Target Population(s)



CBOTEST002
High-Risk Client



CBOTEST003
HIV Medical Care at the time of this positive test



CBOTEST004
Navigation and prevention and essential support services, HIV Testing



CBOTEST004SP
Other recommended support services, HIV testing



CBOTEST005
Date client attended first medical care appointment



 Data Upload




Z03c
Schema Version Number



Z06
Data Type in File



Budget
Health Department PS18-1802 Only



BASTRAT10a1P
Percent Allocated - Monitoring and Evaluation - Prevention


New
BASTRAT10a1S
Percent Allocated - Monitoring and Evaluation - Surveillance


New
BASTRAT11a1P
Percent Allocated - Capacity Building and TA - Prevention


New
BASTRAT11a1S
Percent Allocated - Capacity Building and TA - Surveillance


New
BASTRAT11a2P
Percent Allocated - Geocoding - Prevention


New
BASTRAT11a2S
Percent Allocated - Geocoding - Surveillance


New
BASTRAT1a1S
Percent Allocated – Data Activities - Surveillance


New
BASTRAT1a2P
Percent Allocated – Data Activities - Prevention


New
BASTRAT2a1P
Percent allocated - Routine HIV testing, Healthcare -Prevention


New
BASTRAT2a2P
Percent allocated - Targeted HIV testing, non-Healthcare - Prevention


New
BASTRAT2a3P
Percent allocated - HIV Partner Services - Prevention


New
BASTRAT2a4P
Percent allocated - D2C - Prevention


New
BASTRAT2a4S
Percent expended - D2C - Surveillance


New
BASTRAT3a1P
Percent Allocated - HIV Transmission Clusters and Outbreaks - Prevention


New
BASTRAT3a1S
Percent Allocated - HIV Transmission Clusters and Outbreaks - Surveillance


New
BASTRAT4a1P
Percent Allocated - CPP, Continuum of Care - Prevention


New
BASTRAT4a2P
Percent Allocated - CPP, Risk Reduction Interventions - Prevention


New
BASTRAT4a3P
Percent Allocated - Other CPP - Prevention


New
BASTRAT5a1P
Percent Allocated - Prevention with HIV-negative persons - Prevention


New
BASTRAT5a2P
Percent Allocated - PrEP Access and Support - Prevention


New
BASTRAT5a3P
Percent Allocated - PEP Access and Support - Prevention


New
BASTRAT6a1P
Percent Allocated - Perinatal HIV Exposure Reporting - Prevention


New
BASTRAT6a1S
Percent Allocated - Perinatal HIV Exposure Reporting - Surveillance


New
BASTRAT6a2P
Percent Allocated - Perinatal HIV Surveillance Coordination - Prevention


New
BASTRAT6a2S
Percent Allocated - Perinatal HIV Surveillance Coordination - Surveillance


New
BASTRAT7a1P
Percent Allocated - Community-level Prevention Activities - Prevention


New
BASTRAT7a2P
Percent Allocated - SSP - Prevention


New
BASTRAT7a3P
Percent Allocated - Condom Distribution - Prevention


New
BASTRAT8a1P
Percent Allocated - HIV Planning - Prevention


New
BASTRAT8a1S
Percent Allocated - HIV Planning - Surveillance


New
BASTRAT9a1P
Percent Allocated - Health Information Infrastructure - Prevention


New
BASTRAT9a1S
Percent Allocated - Health Information Infrastructure -Surveillance


New
BASTRAT9a2P
Percent Allocated - Data Security and Confidentiality - Prevention


New
BASTRAT9a2S
Percent Allocated - Data Security and Confidentiality - Surveillance


New
BASTRAT9a3P
Percent Allocated - Policies and Protocols - Prevention


New
BASTRAT9a3S
Percent Allocated - Policies and Protocols - Surveillance


New
BESTRAT10a1P
Percent Expended - Monitoring and Evaluation - Prevention


New
BESTRAT10a1S
Percent Expended - Monitoring and Evaluation  - Surveillance


New
BESTRAT11a1P
Percent Expended - Capacity Building and TA - Prevention


New
BESTRAT11a1S
Percent Expended - Capacity Building and TA - Surveillance


New
BESTRAT11a2P
Percent Expended - Geocoding - Prevention


New
BESTRAT11a2S
Percent Expended - Geocoding - Surveillance


New
BESTRAT1a1S
Percent Expended – Data Activities - Surveillance


New
BESTRAT1a2P
Percent expended - NHME


New
BESTRAT2a1P
Percent expended - Routine HIV testing, Healthcare - Prevention


New
BESTRAT2a2P
Percent expended - Targeted HIV testing, non-Healthcare - Prevention


New
BESTRAT2a3P
Percent expended - HIV Partner Services - Prevention


New
BESTRAT2a4P
Percent expended - D2C - Prevention


New
BESTRAT2a4S
Percent expended - D2C - Surveillance


New
BESTRAT3a1P
Percent Expended - HIV Transmission Clusters and Outbreaks - Prevention


New
BESTRAT3a1S
Percent Expended - HIV Transmission Clusters and Outbreaks - Surveillance


New
BESTRAT4a1P
Percent Expended  - CPP, Continuum of Care - Prevention


New
BESTRAT4a2P
Percent Expended - CPP, Risk Reduction Interventions - Prevention


New
BESTRAT4a3P
Percent Expended - Other CPP - Prevention


New
BESTRAT5a1P
Percent Expended - Prevention with HIV-negative persons - Prevention


New
BESTRAT5a2P
Percent Expended - PrEP Access and Support - Prevention


New
BESTRAT5a3P
Percent Expended - PEP Access and Support - Prevention


New
BESTRAT6a1P
Percent Expended - Perinatal HIV Exposure Reporting - Prevention


New
BESTRAT6a1S
Percent Expended - Perinatal HIV Exposure Reporting - Surveillance


New
BESTRAT6a2P
Percent Expended - Perinatal HIV Surveillance Coordination - Prevention


New
BESTRAT6a2S
Percent Expended - Perinatal HIV Surveillance Coordination - Surveillance


New
BESTRAT7a1P
Percent Expended - Community-level Prevention Activities - Prevention


New
BESTRAT7a2P
Percent Expended - SSP - Prevention


New
BESTRAT7a3P
Percent Expended - Condom Distribution - Prevention


New
BESTRAT8a1P
Percent Expended - HIV Planning - Prevention


New
BESTRAT8a1S
Percent Expended - HIV Planning - Surveillance


New
BESTRAT9a1P
Percent Expended  - Health Information Infrastructure - Prevention


New
BESTRAT9a1S
Percent Expended  - Health Information Infrastructure - Surveillance


New
BESTRAT9a2P
Percent Expended - Data Security and Confidentiality - Prevention


New
BESTRAT9a2S
Percent Expended - Data Security and Confidentiality - Surveillance


New
BESTRAT9a3P
Percent Expended - Policies and Protocols - Prevention


New
BESTRAT9a3S
Percent Expended - Policies and Protocols - Surveillance


New
CSTRATEGY1
Comments - Strategy 1


New
CSTRATEGY10
Comments - Strategy 10


New
CSTRATEGY11
Comments - Strategy 11


New
CSTRATEGY2
Comments - Strategy 2


New
CSTRATEGY3
Comments - Strategy 3


New
CSTRATEGY4
Comments - Strategy 4


New
CSTRATEGY5
Comments - Strategy 5


New
CSTRATEGY6
Comments - Strategy 6


New
CSTRATEGY7
Comments - Strategy 7


New
CSTRATEGY8
Comments - Strategy 8


New
CSTRATEGY9
Comments - Strategy 9


New